As of May 22
| -0.59 / -0.86%|
The 18 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 72.50, with a high estimate of 80.00 and a low estimate of 55.00. The median estimate represents a +6.15% increase from the last price of 68.30.
The current consensus among 23 polled investment analysts is to Hold stock in Bristol-Myers Squibb. This rating has held steady since May, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.